Advances in Experimental Medicine and Biology
DOI: 10.1007/0-306-47932-x_7
|View full text |Cite
|
Sign up to set email alerts
|

HPMA Copolymer Delivery of Chemotherapy and Photodynamic Therapy in Ovarian Cancer

Abstract: Our studies document a unique and unexpected advantage of the combination of HPMA copolymer bound doxorubicin with mesochlorin e6/photodynamic therapy in the treatment of ovarian cancer. Each drug's activity is individually enhanced when compared with free (low molecular weight) drugs, furthermore, in combination these HPMA copolymer bound agents act synergistically to create an unexpected biological effect. Figure 8 depicts the known activities of each agent which may play synergistic roles. HPMA copolymer-do… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
30
0

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 44 publications
(30 citation statements)
references
References 41 publications
0
30
0
Order By: Relevance
“…PDT in combination with surgery [15] , radiotherapy [16] or chemotherapy [17] , has become a subject of research. New photosensitizers with improved spectroscopic, photochemical and tissue-localizing properties and improved laser instrumentation have stimulated attempts to establish clinical protocols for incorporation of PDT into multi-treatment modalities [18][19][20][21][22][23][24] . Most studies on PDT to date have been on lesions of the skin or in the wall of hollow organs, but recent interest is more in its potential for treating lesions of solid organs such as the pancreas [10,11,20] .…”
Section: Introductionmentioning
confidence: 99%
“…PDT in combination with surgery [15] , radiotherapy [16] or chemotherapy [17] , has become a subject of research. New photosensitizers with improved spectroscopic, photochemical and tissue-localizing properties and improved laser instrumentation have stimulated attempts to establish clinical protocols for incorporation of PDT into multi-treatment modalities [18][19][20][21][22][23][24] . Most studies on PDT to date have been on lesions of the skin or in the wall of hollow organs, but recent interest is more in its potential for treating lesions of solid organs such as the pancreas [10,11,20] .…”
Section: Introductionmentioning
confidence: 99%
“…High-molecular-mass compounds as drug delivery vehicles recently attracted special attention because tumors can selectively accumulate these molecules by the enhanced permeability and retention (EPR) effect. It was observed in tumor tissue for macromolecules [7][8][9] and is used for cancer drug delivery. Tumor vasculature can be targeted with a synthetic polymer, N-(2-hydroxypropyl)methacrylamide [8], conjugated with O-(chloracetyl-carbamoyl) fumagillol (TNP-470) [10].…”
Section: Introductionmentioning
confidence: 99%
“…It was observed in tumor tissue for macromolecules [7][8][9] and is used for cancer drug delivery. Tumor vasculature can be targeted with a synthetic polymer, N-(2-hydroxypropyl)methacrylamide [8], conjugated with O-(chloracetyl-carbamoyl) fumagillol (TNP-470) [10]. Another promising drug carrier used here is β-poly(L-malic acid) (PMLA), a natural product of Physarum polycephalum [11][12][13].…”
Section: Introductionmentioning
confidence: 99%
“…Although initial research focused on the use of N-(2-hydroxypropyl) methacrylamide (HPMA) based upon similarity to Ringsdorf's Model, polymers with a variety of architectures and structural elements are currently being explored, including linear mono-and di-functional polymers, star polymers, and dendrimers ( Fig. 3) (Kopecek et al, 2000;Peterson et al, 2003). Dendrimers can alternatively be classified as nanoparticulate carriers when drug molecules are entrapped within the interior rather than covalently linked to the surface functional groups (Gillies & Frechet, 2005;M.…”
Section: Polymer-drug Conjugatesmentioning
confidence: 99%